Protandim

LifeVantage Transforms the Future of Skin Health and Radiance: Introducing the TrueScience® Activated Skin Care Collection

Retrieved on: 
Monday, March 4, 2024

Steve Fife, President and CEO of LifeVantage, expressed his excitement about the new collection: “TrueRenew was just the beginning of a new era of activated skincare for LifeVantage.

Key Points: 
  • Steve Fife, President and CEO of LifeVantage, expressed his excitement about the new collection: “TrueRenew was just the beginning of a new era of activated skincare for LifeVantage.
  • With the TrueScience Activated Skin Care Collection, we've kept the ingredients our customers love and elevated everything else to exceed their expectations.
  • LifeVantage's TrueScience Activated Skin Care Collection directly answers these demands, featuring scientifically-backed ingredients that tackle various skin issues, all while upholding the Company’s commitment to its clean standards.
  • For more information on the Activated Skin Care Collection and to experience the future of skincare, visit the LifeVantage website ( www.lifevantage.com ).

LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference

Retrieved on: 
Friday, February 16, 2024

Mr. Fife and Mr. Aure will meet with investors and present at approximately 2:30 p.m. Eastern Time on Tuesday, February 20, 2024.

Key Points: 
  • Mr. Fife and Mr. Aure will meet with investors and present at approximately 2:30 p.m. Eastern Time on Tuesday, February 20, 2024.
  • A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here .
  • A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.
  • To register for a one-on-one meeting, please visit registration at MicroCap Rodeo .

LifeVantage Appoints Dayton Judd to the Board of Directors

Retrieved on: 
Thursday, February 15, 2024

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company’s Board of Directors (the “Board”), effective immediately, in an expansion of the Board.

Key Points: 
  • SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company’s Board of Directors (the “Board”), effective immediately, in an expansion of the Board.
  • During these discussions, the Company and the Radoff-Sudbury Group worked together to create a framework for long-term collaboration between the parties.
  • The appointment of Dayton Judd to the Board is in connection with a Cooperation Agreement entered into between the Company and the Radoff-Sudbury Group.
  • Steve Fife, LifeVantage’s President and Chief Executive Officer, commented, “We welcome Dayton to the Board and believe his insights and perspective will benefit the Company and its shareholders.

LifeVantage Announces Expansion of LV360 into Canada, Mexico, and European Markets

Retrieved on: 
Wednesday, February 7, 2024

In a highly competitive direct selling market, LifeVantage is keenly aware of the need to stay at the forefront.

Key Points: 
  • In a highly competitive direct selling market, LifeVantage is keenly aware of the need to stay at the forefront.
  • With LV360 and its forward-thinking approach, LifeVantage is well-positioned to capitalize consumer and gig trends, while attracting an expanding Customer base.
  • “Anyone looking for supplemental income and multiple paths to success should look no further than LifeVantage,” said Fife.
  • “We will continue to lead the way in innovation with the very best products and best-in-class Consultant and Customer experiences.”

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2024

Retrieved on: 
Tuesday, January 30, 2024

* All comparisons are on a year over year basis and compare the second quarter of fiscal 2024 to the second quarter of fiscal 2023, unless otherwise noted.

Key Points: 
  • * All comparisons are on a year over year basis and compare the second quarter of fiscal 2024 to the second quarter of fiscal 2023, unless otherwise noted.
  • Operating loss for the second quarter of fiscal 2024 was $1.3 million compared to operating loss of $1.2 million for the second quarter of fiscal 2023.
  • Accounting for non-GAAP adjustments noted previously, adjusted non-GAAP operating income for the second quarter of fiscal 2024 was $1.4 million compared to adjusted non-GAAP operating loss of $0.9 million for the second quarter of fiscal 2023.
  • Adjusted EBITDA was $3.1 million for the second quarter of fiscal 2024, versus $0.8 million for the comparable period in fiscal 2023.

LifeVantage Declares Quarterly Dividend

Retrieved on: 
Tuesday, January 30, 2024

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.035 per share of common stock, which will be paid March 15, 2024 to all stockholders of record at the close of business on March 1, 2024.

Key Points: 
  • SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.035 per share of common stock, which will be paid March 15, 2024 to all stockholders of record at the close of business on March 1, 2024.

LifeVantage to Announce Second Quarter Fiscal Year 2024 Results on January 30, 2024

Retrieved on: 
Tuesday, January 16, 2024

SALT LAKE CITY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its second quarter ended December 31, 2023, after the stock market closes on Tuesday, January 30, 2024.

Key Points: 
  • SALT LAKE CITY, Jan. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its second quarter ended December 31, 2023, after the stock market closes on Tuesday, January 30, 2024.
  • The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
  • Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920.
  • There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1650314&tp_key=bd3485db5e .

LifeVantage Hosts Global Kickoff Announcing “Rise ERA” Theme, New Sales Incentives and Global Expansion Dates for LV360

Retrieved on: 
Tuesday, January 16, 2024

This worldwide event featured the announcement of the Company’s “Rise ERA” theme, the unveiling of the launch date for the next phase of LV360 , new sales incentives, and the launch of new Consultant tools.

Key Points: 
  • This worldwide event featured the announcement of the Company’s “Rise ERA” theme, the unveiling of the launch date for the next phase of LV360 , new sales incentives, and the launch of new Consultant tools.
  • Consultants registered hundreds of watch parties across the globe where attendees received in-person training from their hosts and leaders, in addition to the global announcements.
  • “The launch of LV360 in 2023 helped to catalyze the foundational elements of our strategic transformation, laying the groundwork for long-term success,” said LifeVantage President and CEO Steve Fife.
  • “As LifeVantage begins our Rise ERA, we invite all Consultants to embrace the focus and seize the opportunities that 2024 holds,” added Fife.

LifeVantage Corporation to Participate in Water Tower Fireside Chat Series

Retrieved on: 
Monday, December 11, 2023

SALT LAKE CITY, Dec. 11, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that Steve Fife, CEO, and Carl Aure, CFO, will be participating in the Water Tower Research Fireside Chat Series on Thursday, December 14, 2023, at 11:00 am ET.

Key Points: 
  • SALT LAKE CITY, Dec. 11, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that Steve Fife, CEO, and Carl Aure, CFO, will be participating in the Water Tower Research Fireside Chat Series on Thursday, December 14, 2023, at 11:00 am ET.
  • This event is open access for all investors to participate.
  • Topics may include:
    LifeVantage’s strategy of activating financial, social, and community wellness through its proprietary product portfolio and its connected network of independent consultants.
  • The recent implementation of its LV360 initiatives, including the new Evolve compensation plan for its consultants.

LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen

Retrieved on: 
Wednesday, November 29, 2023

The study results showed that when combined, the products work together to help cells accurately respond to stress levels and recover more quickly, supporting the body’s immune function.

Key Points: 
  • The study results showed that when combined, the products work together to help cells accurately respond to stress levels and recover more quickly, supporting the body’s immune function.
  • “When cells are stressed they send out signals asking for help from the immune system,” explained Lisa Barnes, Vice President of Research & Development.
  • To understand why, Barnes and team devised a study in three parts: a dose-finding study, a gene expression study to verify dose timing and concentration, and a global gene expression study using RNA sequencing.
  • Around 21% (2,786 genes) were significantly up, or downregulated either by Protandim Nrf2 Synergizer®, TrueScience® Liquid Collagen, or a combination of the two.